Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|April 20, 2020
Erdheim-Chester diseaseGordon Starkebaum, Paul Hendrie
Jac-Antimicrobial Resistance|August 6, 2024
Ceftriaxone-resistant viridans streptococci bacteraemia among patients treated at a large comprehensive cancer care centre: a retrospective eighteen-year studyPaula Marsland, Rupali Jain, Frank Tverdek, et al.
Leukemia Research Reports|December 28, 2013
Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML)Victor Chow, Kathleen Shannon Dorcy, Ravinder Sandhu, et al.
Transfusion|May 9, 2012
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literatureKerry L O'Brien, Shalini E Pereira, Jeffrey Wagner, et al.
JCO Oncology Practice|April 3, 2025
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During TreatmentMatthew Wu, Kathryn Russell, Carole M Shaw, et al.
Antimicrobial Resistance and Infection Control|December 12, 2017
Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer centerShobini Sivagnanam, Dhruba J Sengupta, Daniel Hoogestraat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile NeutropeniaEmily A Rosen, Elizabeth M Krantz, Allison Thibodeau, et al.
British Journal of Haematology|November 17, 2015
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDSRaya Mawad, Pamela S Becker, Paul Hendrie, et al.
British Journal of Haematology|April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of ageSarah A Buckley, Raya Mawad, Ted A Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remissionRaya Mawad, Ted A Gooley, Vicky Sandhu, et al.
Pageof 2